Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash provided by (used for) operating activities
Net income (loss)	$ 672	$ 493
Depreciation and amortization	325	304
Deferred and prepaid income taxes	41	31
Stock-based compensation expense	74	63
Net loss (gain) on investments and notes receivable	28	2
Contingent consideration net expense (benefit)	5	17
Inventory step-up amortization	81	0
Other, net	(7)	(4)
Trade accounts receivable	(107)	(114)
Inventories	(109)	(124)
Other assets	(77)	(55)
Accounts payable, accrued expenses and other liabilities	(385)	(450)
Cash provided by (used for) operating activities	541	164
Investing activities:
Purchases of property, plant and equipment and internal use software	(187)	(179)
Payments for acquisitions of businesses, net of cash acquired	(239)	(47)
Payments for investments and acquisitions of certain technologies	(77)	(66)
Other, net	3	7
Cash provided by (used for) investing activities	(500)	(285)
Financing activities:
Payment of contingent consideration previously established in purchase accounting	0	(34)
Payments for royalty rights	(10)	(15)
Payments for finance leases	(36)	(25)
Payments on short-term borrowings	(1,083)	(504)
Net increase (decrease) in commercial paper	(192)	0
Proceeds from long-term borrowings, net of debt issuance costs	1,558	2,145
Cash used to net share settle employee equity awards	(118)	(78)
Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans	115	80
Cash provided by (used for) financing activities	233	1,569
Effect of foreign exchange rates on cash	39	(7)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	314	1,441
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	606	1,055
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	919	2,496
Supplemental Information
Stock-based compensation expense	74	63
Non-cash impact of transferred royalty rights	(4)	(7)
Cash and cash equivalents	725	2,329
Restricted cash and restricted cash equivalents included in Other current assets	103	93
Restricted cash equivalents included in Other long-term assets	91	74
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 919	$ 2,496